Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Glaxosmithkline Biologicals, S.A v. Hospira Worldwide, Inc. et al
Case Number:
1:13-cv-04346
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 19, 2017
Hospira Comes Out $40K Ahead In Verdict Against GSK
An Illinois federal jury concluded on Friday that both GlaxoSmithKline and Hospira were injured by the fallout over a troubled contract to manufacture a flu vaccine and awarded both parties damages, giving Hospira a slight edge of $40,000.
-
May 01, 2017
GSK, Hospira Trade Blame For Failed Flu Vaccine Deal
A GlaxoSmithKline unit went to trial in Illinois on Monday in hopes of convincing a federal jury that fellow pharmaceutical company Hospira owes millions of dollars for breaking a contract to fill syringes with a flu vaccine, but Hospira says it was the one harmed when GSK walked away from the contract without paying up.
-
September 30, 2016
Hospira Can't Escape Contract Claims In GSK Vaccine Suit
An Illinois federal judge Friday ruled that Hospira couldn't escape claims that it breached a contract with GlaxoKlineSmith to produce a flu vaccine, although the judge threw out a claim that Hospira made money when it set aside the agreement.